The evidence is pouring in. M&A activity is bouncing along again. Just in the last three days I read these stories in the WSJ and Boston Globe.
Health-care companies undertook $321 billion of acquisitions last year, more than double the $115 billion in 2013 (WSJ/Dealogic). The majority of health-care and life-science companies that floated last year chose outside CFOs. And the reason according to Korn Ferry – M&A ...Continue Reading →